J2680 Fluphenazine decanoate 25 mgInjection, fluphenazine decanoate, up to 25 mg
J2680 payment limit: $6.174 per 25 MG, effective October 1, 2026 through December 31, 2026, based on 2Q26 ASP data. Coinsurance 20%.
42023-0129-01 Fluphenazine Decanoate, Endo USA, Inc.: 5 billing units per package (1 VIAL in 1 CARTON / 5 mL in 1 VIAL)42023-0129-89 Fluphenazine Decanoate, Endo USA, Inc.: 5 billing units per package (1 VIAL in 1 CARTON / 5 mL in 1 VIAL)55150-0267-05 Fluphenazine Decanoate, Eugia US LLC: 5 billing units per package (1 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE)63323-0272-05 Fluphenazine Decanoate, FreseniUS Kabi USA, LLC: 5 billing units per package (1 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE)00143-9529-01 Fluphenazine Decanoate, Hikma Pharmaceuticals USA Inc.: 5 billing units per package (1 VIAL, MULTI-DOSE in 1 BOX / 5 mL in 1 VIAL, MULTI-DOSE)67457-0359-59 Fluphenazine Decanoate, Mylan Institutional LLC: 5 billing units per package (1 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE)72205-0100-01 Fluphenazine Decanoate, Novadoz Pharmaceuticals LLC: 5 billing units per package (1 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE)25021-0838-05 Fluphenazine Decanoate, Sagent Pharmaceuticals: 5 billing units per package (1 VIAL in 1 CARTON / 5 mL in 1 VIAL)Status E: excluded from the PFS by regulation.
1 of 3 payer prior-auth lists that name J2680 require prior authorization or set conditions: UnitedHealthcare Community Plan.
| Payer | Plan | State | Prior auth | Conditions | Since | Source |
|---|---|---|---|---|---|---|
| UnitedHealthcare Community Plan | KanCare | KS | prior auth required | Oct 1, 2026 | Prior authorization requirements for Kansas Medicaid Effective October 1, 2026 |
J2680 appears in 3 coverage policies from Aetna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Electroconvulsive Therapy (0445) | listed, no stance | Jul 29, 2026 | payer document |
| Aetna | Injectable Medications (0020) | listed, no stance (range J2550-J3520) | Mar 5, 2026 | payer document |
| Aetna | Tourette's Syndrome (0480) Tetrabenazine | covered if criteria are met | Jul 24, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.